Researchers at King Khalid University, Warsaw University of Technology and Saveetha University have used molecular docking, molecular dynamics simulations, and computational toxicity screening to examine whether adding graphene oxide (GO) to hydroxyapatite (HA) dental implant coatings could improve how strongly bone-related proteins bind to the implant surface. In their entirely computational study, the team modeled how a set of extracellular matrix (ECM) proteins and integrin receptors interact with simulated GO, HA, and combined GO-HA surfaces.
Titanium dental implants are mechanically strong but biologically inert, which can slow the early bone-implant bonding (osseointegration) that determines whether an implant takes hold. Hydroxyapatite coatings, which chemically resemble bone mineral, are already used to help bridge that gap, but the researchers note that HA coatings show inconsistent protein binding and can delaminate over time. GO has drawn interest as an additive because its high surface area and oxygen-containing functional groups (hydroxyl, carboxyl, epoxide) can, in principle, promote stronger protein adsorption - but GO also carries known dose-dependent cytotoxicity concerns, which is part of what this study set out to weigh.
The team modeled how a wide panel of bone-related proteins and receptors interact with three surface types: graphene oxide alone, hydroxyapatite alone, and the two combined. Hydroxyapatite alone bound most strongly to laminin, a protein involved in cell adhesion, but graphene oxide alone outperformed it across most of the panel, and the combined surface outperformed both individually. The single strongest result in the study involved a receptor called α5β1 - the primary docking point for fibronectin, a protein central to how cells attach to an implant - where the combined graphene oxide-hydroxyapatite surface showed the tightest and most stable predicted binding of anything tested. Follow-up simulations of the top-performing combinations, run over a simulated 100-nanosecond period, found the graphene oxide-hydroxyapatite surface consistently held its protein partners in a more stable position than either material alone, reinforcing the docking results.
The toxicity picture was more mixed. Computational screening flagged GO alone as carrying a high predicted risk across all four toxicity endpoints tested (mutagenicity, tumorigenicity, reproductive toxicity, and irritation), while HA alone showed none. The researchers suggest that embedding GO within an HA matrix might neutralize some of GO's reactive surface chemistry and reduce this risk, but they're explicit that this is an untested hypothesis - the toxicity tools used were run on GO and HA separately, not on the combined nanocomposite, since existing platforms can't model a GO-HA composite directly.
The authors commented on the limits of this study: the computational model doesn't establish an actual covalent bond between GO and HA, doesn't capture coating morphology or crystallinity, and can't account for competing serum proteins, immune responses, or mechanical loading in a real mouth. They describe the result as a hypothesis-generating framework rather than evidence of clinical performance, and call for follow-up work - surface characterization, osteoblast cell-culture testing, and eventually animal implantation studies - before any GO-HA coating could be evaluated for real-world use.
